KALV | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  12115 of 12268  at  7/1/2020 8:30:56 AM  by

roddog


KALV


KalVista Pharmaceuticals Says KVd900 Phase 2 Clinical Trial For Oral Treatment Of Hereditary Angioedema (HAE) Data Expected In 2H 2020; Oral HAE Prophylactic Candidate KVD824 Phase 2 Clinical Trial Planned To Commence In 2H 2020


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 129
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...